entertainment -WSS

entertainment

author：knowledge 2025-09-28 22:28:34 - browse：1

Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store. — The FDA is ramping up its efforts to force vape shops and other retailers to stop selling Elf Bar and Esco Bar products. PATRICK T. FALLON/AFP via Getty Images

WASHINGTON — The Food and Drug Administration is ramping up its efforts to force vape shops and other retailers to stop selling unauthorized disposable vape brands that are increasingly popular with young people.

The FDA recently issued 189 formal warning letters to shops selling two brands of vape products, Elf Bar and Esco Bars, the agency announced in a press release Thursday. The FDA has not authorized either brand, both of which are ubiquitous in gas stations and smoke shops around the country. They are therefore illegal to sell.

“This latest blitz should be a wake-up call for retailers of Elf Bar and Esco Bars products nationwide,” said Brian King, the head of the FDA’s tobacco center in a statement announcing the blitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： UnitedHealth quietly bought dozens of outpatient centers

Wikipedia

WSS

Generate Biomedicines machine learning biotech raises $273M

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Long Covid needs a new name — and a new frame

Change Healthcare payments predicted restored March 15

FDA panel endorses Alnylam’s heart drug — after picking it apart

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Wikipedia

entertainment

entertainment

Jerome Adams on the need for new antivirals for Covid

White House touts steps to stem shortages of cancer treatments

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The drug industry has found itself all alone in Washington

ChatGPT in medicine: STAT answers readers' burning questions

Will the IRA bring competition to the biologics market?

Walensky prepares to leave CDC — and Congress — behind

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Hollywood unions extend contract negotiations for actors

New Covid vaccine is recommended for everyone 6 months or older

focus

IRA could hurt research into orphan drugs for rare diseases

PEPFAR is under serious threat — and so is global health

Amylyx ALS drug fails large clinical trial

UnitedHealth quietly bought dozens of outpatient centers

Telehealth for opioid use disorder is lifesaving

With psoriasis trial ahead, Alumis raises $259 million

Wikipedia

hotspot

focus

Wikipedia